Skip to content

CUE - Cue Biopharma, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Cue Biopharma

CUE · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CUECue Biopharma

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $45.50
52-wk low: $4.97
Prev close: $24.14
Mkt cap: $190.9M
Beta: 2.47
P/S: 5.7x

Smart money

5 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

5 holders

Combined position$3.3M

CI
Citadel
Ken Griffin · Q2 2026 13F
$809K
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 14, 2026

Earnings came in $12.12 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -59.7%
Market cap: $191M

Valuation

P/S5.70
P/B86.92

Quality

Operating margin-94.3%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CUE
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $190.91M
Beta: 2.47

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

86.9x

Profit margin

-59.7%

Op margin

-94.3%

ROE

-138.5%

$464K

position

BR

BlackRock

Q2 2026 13F

$1.8M

position

2 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 2 holders

Coverage gaps for CUE

No recent Congress trade
No recent market-voice mention

Earnings per share

-$13.81-$12.12

-$1.69 expected

Next report

What the street expects next

EPS expected

-$1.42

-$1.42 to -$1.42

Revenue expected

$2.1M

1 analysts

Last 30 days

1up1down

Split both ways

Estimate drift

+0.49

Change in 30 days

-138.5%

ROA-46.1%

Growth

Beta2.47